Abstract
The Latino/Hispanic population constitutes the largest minority group in the country, accounting for 16 % of the total U.S. population. It is a heterogeneous group with several racial, biological, social, and cultural backgrounds. In general, the prevalence of traditional cardiovascular risk factors such as type 2 diabetes, hypertension, dyslipidemia and obesity is quite elevated and imposes a tremendous challenge to the health care system. According to the recently reported baseline characteristics of Latinos/Hispanics participating in the Hispanic Community Health Study/Study of Latinos, the prevalence of hypercholesterolemia was 52 % in men and 37 % in women. The prevalence of hypertension was 27 % in men and 25 % in women; the prevalence of diabetes was 16.7 % in men and 17.2 % in women; the prevalence of obesity was 36.5 % in men and 42.6 % in women and the prevalence of smoking was 26 % in men and 15 % in women. Studies performed by the Latino Diabetes Initiative at the Joslin Diabetes Center in Boston have identified significant endothelial dysfunction and vascular inflammation in overweight young Hispanic adults with a mean of 29 years of age and parental history of type 2 diabetes as well as in normoglycemic, normotensive, non-dyslipidemic overweight Hispanic children and adolescents with a mean of 13 years of age. Thus, the Hispanic/Latino population exhibits a high cardiovascular risk and therefore, effective preventive strategies are needed to tackle the burden of frequent and significant metabolic and vascular abnormalities in this population.
Similar content being viewed by others
References
Ennis S, Rios-Vargas M, Albert N. 2010 census briefs: the Hispanic population: 2010. US Census Bureau. Available at: http://www.census.gov/prod/cen2010/briefs/c2010br-04.pdf. Accessed 1 Sept 2013.
US Census Bureau, 2004, U.S. interim projections by age, sex, race, and Hispanic origin. Available at: http://www.census.gov/ipc/www/usinterimproj/. Accessed 1 Sept 2013.
Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care. 2006;29:1263–8.
Narayan KM, Boyle JP, Thompson TJ, et al. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003;290:1884–90.
Keenan NL, Rosendorf KA. Centers for Disease Control and Prevention (CDC). Prevalence of hypertension and controlled hypertension: United States, 2005–2008. MMWR Surveill Summ. 2011;60(Suppl):94–7.
Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010;303:235–41.
Caballero AE. Understanding the Hispanic/Latino patient. Am J Med. 2011;124:S10–5.
Hunt KJ, Williams K, Resendez RG, et al. All-cause and cardiovascular mortality among diabetic participants in the San Antonio Heart Study: evidence against the “Hispanic Paradox. Diabetes Care. 2002;25:1557–63.
Roger VL, Go AS, Lloyd-Jones DM, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics: 2012 update: a report from the American Heart Association. Circulation. 2012;125:e2–220.
Institute of Medicine. Unequal treatment: confronting racial and ethnic disparities in health care. The National Academies Press. Washington, DC; 2004. Available at: www.iom.edu. Accessed 1 Aug 2009.
Merriam-Webster Dictionary. Available at: http://www.m-w.com. Accessed 1 Aug 2009.
Davligus ML, Talavera GA, Aviles-Santa ML, et al. Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA. 2012;308:1775–84.
Mendivil CO, Robles-Osorio L, Horton ES, Hamdy O, Caballero AE. Young Hispanics at risk of type 2 diabetes display endotelial activation, subclinical inflammation and alterations of coagulation and fibrinolysis. Diabetol Metab Syndr. 2013;5:37.
Caballero AE, Bousquet-Santos K, Robles-Osorio L, et al. Overweight Latino children and adolescents have marked endothelial dysfunction and subclinical vascular inflammation in association with excess body fat and insulin resistance. Diabetes Care. 2008;31:576–82.
The Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.
Goran MI, Ball GD, Cruz ML. Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents. J Clin Endocrinol Metab. 2003;88:1417–27.
Kieffer EC, Tabael BP, Carman WJ, et al. The influence of maternal weight and glucose tolerance on infant birth weight in Latino mother-infant pairs. Am J Pub Health. 2006;96:2201–8.
Caballero AE. Endothelial dysfunction, inflammation and insulin resistance: a focus on subjects at risk for type 2 diabetes. Curr Diab Rep. 2004;4:237–46.
La Rosa JC, Brown CD. Cardiovascular risk factors in minorities. Am J Med. 2005;118:1314–22.
Compliance with Ethics Guidelines
Conflict of Interest
Enrique Caballero declares that he has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Caballero, A.E. Cardiometabolic Risk in the Latino/Hispanic Population. Curr Cardiovasc Risk Rep 7, 433–437 (2013). https://doi.org/10.1007/s12170-013-0361-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12170-013-0361-6